IL-18 promoter polymorphisms confer susceptibility to Behçet's disease, particularly to the mucocutaneous form, in a Turkish population

Clinical and Experimental Rheumatology

Volumn 27, Issue 2 SUPPL.53, 2009, Pages

  Keskin, F ^a   Pay, Salih ^a   Musabak, U ^a   Sagkan, R I ^a   Erdem, H ^a   Simsek, I ^a   Kose, O ^a   Dinc, A ^a   Sengul, A ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 18;

ADULT; BEHCET DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; TURKEY (REPUBLIC);

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BEHCET SYNDROME; CASE-CONTROL STUDIES; FEMALE; HAPLOTYPES; HUMANS; INTERLEUKIN-18; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; TURKEY; YOUNG ADULT;

EID: 70350154312     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (9)

1. YAMAMURA M, KAWASHIMA M, TANIAI M et al.: Interferon-gamma-inducing activity of interleukin-18 in the joint with rheumatoid arthritis. Arthritis Rheum 2001; 44: 275-285 (Pubitemid 32207020)
2. NAKANIHI K, YOSHIMOTO T, TSUTSUI H, OKAMURA H: Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 2001; 19: 423-74.
3. HAMZAOUI K, HAMZAOUI A, GUEMIRA F, BESSIOUD M, HAMZA M, AYED K: Cytokine profile in Behçet's disease patients. Relationship with disease activity. Scand J Rheumatol 2002; 31: 205-211
4. OZTAS MO, ONDER M, GÜRER MA, BUKAN N, SANCAK B: Serum interleukin 18 and tumour necrosis factor-a levels are increased in Behçet's disease. Clin Exp Dermatol 2005; 30: 61.
5. HAMZAOUI A, GHRAIRI H, AMMAR J, ZEKRI S, GUEMIRA F, HAMZAOUI K: IL-18 mRNA expression and IFN-c induction in bronchoalveolar lavage from Behçet's disease. Clin Exp Rheumatol 2003; 21: S8-12.
6. MUŞABAK U, PAY S, ERDEM H et al.: Serum interleukin-18 levels in patients with Behçet's disease. Is its expression associated with disease activity or clinical presentations? Rheumatol Int 2006; 26: 545-550
7. THOMPSON SR, HUMPHRIES SE: Interleukin-18 genetics and inflammatory disease susceptibility. Genes Immun 2007; 8: 91-99 (Pubitemid 46390906)
8. JANG WC, PARK SB, NAM YH et al.: Interleukin-18 gene polymorphisms in Korean patients with Behçet's disease. Clin Exp Rheumatol 2005; 23 (Suppl. 38): S59-63.
9. LEE YJ, KANG SW, PARK JJ et al.: Interleukin-18 promoter polymorphisms in patients with Behçet's disease. Hum Immunol 2006; 67: 812-818 (Pubitemid 44572598)